Time in Range: How CGM Metrics Can Transform Diabetes Management

Most people with diabetes know their HbA1c number. It’s the number doctors check every three months to see how well blood sugar is controlled. But here’s the problem: HbA1c only gives you an average. It doesn’t tell you when your blood sugar spikes after lunch, crashes in the middle of the night, or stays high for hours after a walk. That’s where Time in Range comes in.

What Time in Range Really Means

Time in Range, or TIR, is simple: it’s the percentage of time your blood glucose stays between 70 and 180 mg/dL (3.9-10.0 mmol/L). That’s the sweet spot where your body functions best, without the risks of low or high blood sugar. For most adults with type 1 or type 2 diabetes, the goal is to hit at least 70% TIR - which means spending just over 17 hours a day in that safe zone.

This number isn’t theoretical. It’s measured by continuous glucose monitors (CGMs), devices worn on the arm or belly that check your glucose every 5 minutes. Over a 14-day period, that’s up to 20,000 data points. That’s not just a number - it’s a detailed map of your daily glucose journey.

Compare that to HbA1c. HbA1c is like reading the summary of a book. TIR is reading every chapter. You can have two people with the same HbA1c of 7.0%, but one spends 80% of the day in range, while the other spends 40% of the day above 180 mg/dL and 10% below 70 mg/dL. That second person is at much higher risk - even if their average looks fine.

Why TIR Matters More Than You Think

High blood sugar doesn’t just show up as a number on a meter. It damages blood vessels, nerves, and organs over time. But those spikes? They’re often invisible without CGM. One patient in Birmingham, who’d been told his HbA1c was “perfect,” discovered through his CGM that his blood sugar shot above 220 mg/dL every time he ate oatmeal. He thought it was a healthy choice. Turns out, the fiber didn’t help - the added sugar in flavored oats did. He switched to plain oats with berries. His TIR jumped from 58% to 82% in six weeks.

Low blood sugar is even more dangerous. Hypoglycemia can cause falls, seizures, or even death. TIR doesn’t just tell you how often you go low - it shows you when and why. Maybe your insulin dose is too high before bed. Maybe you skip snacks after exercise. CGM data turns guesswork into action.

The 2025 American Diabetes Association (ADA) Standards of Care now say CGM should be considered for all adults with type 2 diabetes on glucose-lowering meds - not just those on insulin. That’s a game-changer. Millions of people who thought they didn’t need CGM now have a clear path to better control.

The Numbers Behind the Metric

Here’s what the data shows:

• For every 10% increase in TIR, HbA1c drops by about 0.5%
• People with TIR above 70% have 40% fewer diabetes-related hospital visits
• Time Below Range (TBR) under 4% (less than 1 hour/day below 70 mg/dL) is linked to lower risk of severe lows
• Time Above Range (TAR) under 25% (less than 6 hours/day above 180 mg/dL) reduces long-term complications

Some researchers are now looking at “Time in Tight Range” - staying between 70 and 140 mg/dL. That’s the range most people without diabetes spend most of their day in. It’s harder to achieve, but for some, especially those with prediabetes or early type 2, it’s a realistic target.

How CGM Turns Data Into Daily Wins

CGM isn’t just a tool for tracking. It’s a teacher. You start seeing patterns:

• Why does your glucose spike 90 minutes after coffee?
• Why does your blood sugar drop after a 20-minute walk but not after a 45-minute one?
• Why does your morning number always rise, even if you didn’t eat?

These aren’t random. They’re clues. One woman in her 60s noticed her glucose jumped every time she took her evening walk after dinner. She thought walking was helping. But the CGM showed she was walking on an empty stomach - her body was releasing stress hormones to make up for low fuel. She started eating a small apple before her walk. Her nighttime lows disappeared. Her TIR improved by 15%.

CGM also helps with medication timing. If you take a pill or shot that peaks at 2 hours, you can now see if it’s working right after meals. No more guessing. No more “I hope it worked.”

Barriers - And How to Overcome Them

Yes, CGM costs money. Yes, some insurance plans still make it hard to get. But things are changing fast. In the U.S., Medicare coverage for CGM in type 2 diabetes jumped from 15% in 2019 to 42% in 2023. In the UK, NHS access is expanding, especially for those with frequent lows or unstable control.

Some people worry about the sensor. It’s true - wearing a device for two weeks can feel annoying. But newer sensors are thinner, stickier, and more comfortable. Most people forget they’re wearing it after day two.

And the data? It can feel overwhelming. That’s why working with a diabetes educator matters. You don’t need to be a scientist. You need to know: What does this line mean? Why did it dip here? What should I try tomorrow? A 30-minute session with a certified educator can turn confusion into clarity.

What Comes Next

The future of diabetes care isn’t just about numbers. It’s about personalization. AI tools are already being tested to predict glucose swings before they happen. Imagine your CGM saying: “Your glucose will drop in 45 minutes. Eat a snack now.” That’s not sci-fi - it’s coming.

And as research grows, we’ll get better at linking TIR to real outcomes. We already know that higher TIR means fewer hospital visits. Now, we’re starting to see connections to kidney health, nerve damage, and vision - things HbA1c never showed clearly.

For people with type 2 diabetes, especially those not on insulin, this is the first time they’ve had real-time feedback on their glucose. No more waiting three months for a lab result. No more guessing what went wrong.

Time in Range isn’t just a metric. It’s freedom. Freedom to eat without fear. To move without panic. To sleep without dread. It’s not about perfection. It’s about staying in the zone - most of the time.